ILSI-Biomed 2009 attracted 6,000 industry players, engineers and scientists, with 800 participants from 35 countries and more than 2,500 one-on-one meetings. This year’s 9th annual ILSI-Biomed event will build on the great reputation established over the past decade by offering participants a winning mix of keynote industry speakers, medical device and biopharma company presentations, and three days of exhibition and exclusive networking opportunities.
The ILSI-Biomed 2010 Conference will feature the most acclaimed international speakers discussing the industry’s most pressing topics, such as cardiology, vaccines, oncology, cell therapy, personalized medicine, metabolic diseases, e-health and aesthetic medicine markets.
ILSI Biomed 2010 Conference will focus on:
- The role of innovation, its source – industry or academia? Who will pay for it? – venture capital or large medical and biopharma companies?
- Regulatory changes and their impact on innovation
- Does personalized medicine mean smaller target markets?
- Who is better suited to commercialize future “niche” products? Large players or innovative fully integrated companies. How would it impact business models?
click here for the conference program